Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


a. trombótico-a, rel. a la trombosis o que padece de ella.
Mentioned in ?
References in periodicals archive ?
Objective: To determine the frequency of prothrombin G20210A gene mutation in pregnant females with adverse thrombotic obstetric complication and to compare it with prothrombin G20210A gene's frequency in control population.
GENEVA -- Careful skin examination in patients known to have systemic lupus erythematosus (SLE) can reveal subtle findings indicative of systemic thrombotic vasculopathy warranting prompt initiation of long-term antiplatelet therapy, Dan Lipsker, MD, PhD, said in a plenary lecture at the annual congress of the European Academy of Dermatology and Venereology
Although fetal thrombotic vasculopathy diagnosis has been emphasized recently, (1-4) it is still an underrecognized, clinically important entity that should be identified during placental examination.
NASDAQ: OMER) presented a case report of a patient having co-existing hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA) and graft-versus-host disease (GvHD), which both resolved following OMS721 treatment, the company said.
Causes of TMA include thrombotic thrombocytopenic purpura, haemolytic uraemic syndrome, drug-induced TMA, HELLP syndrome, systemic infections and autoimmune disorders amongst many.
Moreover, a more recent grouping of disorders encompassing microangiopathic hemolytic anemia has been proposed known as the primary thrombotic microangiopathy syndromes.
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder that occurs due to deficiency of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13), which is a von Willebrand factor (VWF) cleaving protein.
After 2 years, the number of thrombotic episodes was significantly lower by 71% in the vitamin group than in the placebo group (5 vs.
Global Markets Direct's, 'Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2015', provides an overview of the Thrombotic Thrombocytopenic Purpura's therapeutic pipeline.
Medicines Company (NASDAQ:MDCO), a pharmaceutical company focused on the treatment of critical care patients, has received approval from the US Food and Drug Administration for its Kengreal (cangrelor) as an adjunctive therapy to percutaneous coronary intervention for decreasing periprocedural thrombotic events in patients who have not been treated with a P2Y12 inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor, it was reported on Tuesday.
USPRwire, Fri Nov 14 2014] Global Markets Direct's, 'Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2014', provides an overview of the Thrombotic Thrombocytopenic Purpura's therapeutic pipeline.